IMMUNE ONCIA THERAPEUTICS INC. Trademark
Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for IMMUNE ONCIA THERAPEUTICS INC. with the United States Patent and Trademark Office. The USPTO has given the IMMUNE ONCIA THERAPEUTICS INC. trademark a serial number of 79422542. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 24, 2025. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNE ONCIA THERAPEUTICS INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements.
General Information
| Serial Number | 79422542 |
| Word Mark | IMMUNE ONCIA THERAPEUTICS INC. |
| Filing Date | Tuesday, December 31, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, April 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | IMMUNE ONCIA THERAPEUTICS INC |
| Goods and Services | Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 24, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ImmuneOncia Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
Trademark Events
| Event Date | Event Description |
| Thursday, April 24, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, April 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 28, 2025 | APPLICATION FILING RECEIPT MAILED |
